Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Safety and Feasibility of Endoscopic Ultrasound (EUS)-Guided Radiofrequency Ablation (RFA) for Solid Pancreatic Neoplasms

NCT03435770 is registered in ClinicalTrials.gov with Singapore General Hospital as lead sponsor.

NCT NCT03435770
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03435770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Safety and Feasibility of Endoscopic Ultrasound (EUS)-Guided Radiofrequency Ablation (RFA) for Solid Pancreatic Neoplasms
Lead sponsor
Singapore General Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
March 1, 2018
Completion date
September 1, 2019
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic adenocarcinoma, pancreatic cancer, pancreatic ductal adenocarcinoma, pancreatic neoplasms, pancreatic neuroendocrine tumor